Mr Daniel Schreyer
- Marie Curie Early Stage Researcher (Therapeutic Science Research)
The University of Glasgow uses cookies for analytics and advertising. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar helps us to understand and improve our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Marketing cookies are used to ensure our marketing content is relevant, timely and interest based. They allow our approved partner to measure effectiveness and serve appropriate and personalised marketing messages on other websites based on your activity on glasgow.ac.uk
Zeng, S. et al. (2022) CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Journal of Experimental and Clinical Cancer Research, 41, 241. (doi: 10.1186/s13046-022-02443-w) (PMID:35945614)
Schreyer, D., Neoptolemos, J. P., Barry, S. T. and Bailey, P. J. (2022) Deconstructing pancreatic cancer using next generation-omic technologies–from discovery to knowledge-guided platforms for better patient management. Frontiers in Cell and Developmental Biology, 9, 795735. (doi: 10.3389/fcell.2021.795735) (PMID:35096825) (PMCID:PMC8793685)
Zeng, S. et al. (2022) CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Journal of Experimental and Clinical Cancer Research, 41, 241. (doi: 10.1186/s13046-022-02443-w) (PMID:35945614)
Schreyer, D., Neoptolemos, J. P., Barry, S. T. and Bailey, P. J. (2022) Deconstructing pancreatic cancer using next generation-omic technologies–from discovery to knowledge-guided platforms for better patient management. Frontiers in Cell and Developmental Biology, 9, 795735. (doi: 10.3389/fcell.2021.795735) (PMID:35096825) (PMCID:PMC8793685)